Clinical Trials Update: Oct. 2, 2003
Alzheimer's Disease Migraine and Cluster Headaches Acne
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
A study to assess the efficacy of a currently marketed prescription drug approved for the treatment of mild to moderate Alzheimer's disease. Volunteers between the ages of 50 and 90 who have a diagnosis of probable Alzheimer's disease, are in generally good health, and have a caregiver who will participate in the study may be eligible. Research sites located throughout the United States.
Migraine and Cluster Headaches
A research study investigating an oral medication already approved for the treatment of migraine pain in adults to determine whether it reduces migraine pain in adolescents. Volunteers between 12 and 17 years old who have at least a one-year history of migraine headaches and have an average of 1 to 6 moderate to severe migraine attacks per month may be eligible. Research sites located throughout the United States.
A research study to test the effectiveness of an investigational medication for the treatment of acne. Female volunteers ages 14-45 who have moderate facial acne may be eligible. Research sites located throughout the United States.
Copyright 2003 CenterWatch. All rights reserved.